Strong Innovation Portfolio Yeda manages a diverse portfolio of intellectual property across fields such as medical therapies, biotechnology, nanotechnology, environmental sciences, and electronics, presenting numerous opportunities for collaboration, licensing, and joint ventures across multiple high-growth sectors.

High Revenue Potential With annual revenues between 25 and 50 million dollars derived from successful licensing and commercialization, Yeda demonstrates robust financial performance, making it a promising partner for companies seeking innovative technologies with proven market traction.

Strategic Partnerships Yeda has established collaborations with leading biotech and pharmaceutical companies, including Lysogene and BioLeaders, indicating a strong propensity for forming strategic alliances, which can facilitate co-development and licensing opportunities for industry partners.

Cutting-Edge Technologies The company specializes in medically and scientifically advanced fields such as gene therapy, cancer treatments, and diagnostic tools, allowing sales teams to target innovative healthcare providers and biotech firms aiming to expand their technological capabilities.

Global Market Access As the commercial arm of one of the world's leading research institutes, Yeda's exclusive rights to market groundbreaking inventions provide access to a pipeline of high-impact innovations suitable for commercialization in international markets.